Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
Fidec Corporation
Xavier Sáez-Llorens; Ananda S Bandyopadhyay; Christopher Gast; Tirza De Leon; Rodrigo DeAntonio; Jose Jimeno; Maria Isabel Caballero; Gabriela Aguirre; M Steven Oberste; William C Weldon; Jennifer L Konopka-Anstadt; John Modlin; Novilia S Bachtiar; Alan Fix; John Konz; Ralf Clemens; Sue Ann Costa Clemens; Ricardo Rüttimann